Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer After BCG Failure

NCT03274284 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03274284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03274284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer After BCG Failure
Lead sponsor
Assiut University
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2017
Completion date
December 31, 2019
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer